1 High-Yield Dividend Stock That's Too Cheap to Ignore

Core Viewpoint - Investors are facing significant market volatility, making it essential to consider companies that can perform well regardless of economic conditions, such as Bristol Myers Squibb, which offers a solid dividend stock opportunity [1]. Group 1: Company Overview - Bristol Myers Squibb is a leading player in the defensive pharmaceutical industry, known for its essential lifesaving drugs that maintain consistent demand through various economic conditions [2]. - The company's portfolio includes oncology, immunology, and rare diseases, although it has faced challenges due to patent cliffs, resulting in modest revenue growth [3]. Group 2: Financial Performance - In the fourth quarter, Bristol Myers reported sales of $12.5 billion, reflecting a year-over-year increase of only 1% [3]. - The growth portfolio, primarily consisting of therapies approved since 2019, generated $7.4 billion in sales during the fourth quarter, marking a 16% year-over-year increase [6]. Group 3: Dividend and Valuation - Bristol Myers offers a forward dividend yield of 4.2%, significantly higher than the S&P 500 average of 1.2%, and has increased its dividends by 65.8% over the past decade [6]. - The company's cash payout ratio stands at 39.3%, indicating potential for further dividend growth [6]. - Currently, Bristol Myers is trading at 9.5 times forward earnings, which is below the healthcare sector's average of 17.1 times [7].